Skip to content
DraconiticResearch
Search Sources API
197,785 studies31 sourcesUpdated 59 min ago
Peer-reviewedCC BYMedicina (Kaunas, Lithuania)

C-Peptide Changes and Glycemic Response During DPP-4 Versus SGLT2 Inhibitor Therapy in Type 2 Diabetes: The Role of Baseline C-Peptide

  1. 1Department of Internal Medicine, Adana City Training and Research Hospital, Adana 01230, Türkiye
  2. 2Department of Internal Medicine, 5 Ocak State Hospital, Adana 01210, Türkiye

Related

  1. Chronic Proton Pump Inhibitor Use and Glycemic Control in Older Adults with Type 2 Diabetes Mellitus: A Retrospective Cross-Sectional Study
    Safiye Kübra Çetindağ Karatlı, Hatice Ergin, Merve Duygu Yurtbay +1
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Case report: Glycemic instability despite fasting C-peptide recovery during sequential somatostatin receptor ligand therapy in acromegaly with diabetes
    Yewen Zhu, Yunwen Tao, Qimin Ding +5
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Endocrinology & metabolismCrossref
  3. Antenatal Corticosteroids in Gestational Diabetes: A Systematic Review of Glycemic Response and Management Strategies
    Alexandra Katz, Aidan Shulkin, Samantha Jacobson +9
    Diabetes, Obesity & MetabolismPeer-reviewedCC BY-NC 4.0Full textObstetrics, gynaecology & paediatricsPMC
  4. Acute glycemic responses to meal-associated alcoholic beverages and ethanol in adults with type 2 diabetes: a systematic review
    Jiahao Li, Huizhi Yang
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  5. The effect of cognitive behavioral therapy for sleep and glycemic outcomes in people with diabetes : A systematic review and meta-analysis
    Yuxiao Jiao, Xiaofei He, Lulu Ma +3
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{alisan2026cpeptide,
  title = {{C-Peptide Changes and Glycemic Response During DPP-4 Versus SGLT2 Inhibitor Therapy in Type 2 Diabetes: The Role of Baseline C-Peptide}},
  author = {İrfan Alişan and Kubilay Akbal and Çisem Yılmaz and Cahit Dinçer and Bektaş Işık and Ahmet Gazi Mustan and Fatih Necip Arıcı and Hüseyin Ali Öztürk and Hilmi Erdem Sümbül},
  journal = {Medicina (Kaunas, Lithuania)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13706689},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - C-Peptide Changes and Glycemic Response During DPP-4 Versus SGLT2 Inhibitor Therapy in Type 2 Diabetes: The Role of Baseline C-Peptide
AU  - İrfan Alişan
AU  - Kubilay Akbal
AU  - Çisem Yılmaz
AU  - Cahit Dinçer
AU  - Bektaş Işık
AU  - Ahmet Gazi Mustan
AU  - Fatih Necip Arıcı
AU  - Hüseyin Ali Öztürk
AU  - Hilmi Erdem Sümbül
PY  - 2026
DA  - 2026/10/01
JO  - Medicina (Kaunas, Lithuania)
UR  - https://europepmc.org/article/PMC/PMC13706689
SN  - 1010-660X
SN  - 1648-9144
ER  -